Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Age- and low back pain-related differences in trunk muscle activation during one-legged stance balance task.

da Silva RA, Vieira ER, Léonard G, Beaulieu LD, Ngomo S, Nowotny AH, Amorim CF.

Gait Posture. 2019 Mar;69:25-30. doi: 10.1016/j.gaitpost.2019.01.016. Epub 2019 Jan 11.

PMID:
30658312
2.

Lumbar stabilisation exercises versus back endurance-resistance exercise training in athletes with chronic low back pain: protocol of a randomised controlled trial.

Nowotny AH, Calderon MG, de Souza PA, Aguiar AF, Léonard G, Alves BMO, Amorim CF, da Silva RA.

BMJ Open Sport Exerc Med. 2018 Nov 22;4(1):e000452. doi: 10.1136/bmjsem-2018-000452. eCollection 2018.

3.

Back muscle fatigue of younger and older adults with and without chronic low back pain using two protocols: A case-control study.

da Silva RA, Vieira ER, Cabrera M, Altimari LR, Aguiar AF, Nowotny AH, Carvalho AF, Oliveira MR.

J Electromyogr Kinesiol. 2015 Dec;25(6):928-36. doi: 10.1016/j.jelekin.2015.10.003. Epub 2015 Oct 23.

PMID:
26542483
4.

Electromyographic activity of knee stabilizer muscles during six different balance board stimuli after anterior cruciate ligament surgery.

Pereira HM, Nowotny AH, Santos AB, Cardoso JR.

Electromyogr Clin Neurophysiol. 2009 Mar-Apr;49(2-3):117-24.

PMID:
19400407
5.

Antisperm antibodies detected by mixed agglutination reaction and immunobead test are not associated with chronic inflammation and infection of the seminal tract.

Marconi M, Nowotny A, Pantke P, Diemer T, Weidner W.

Andrologia. 2008 Aug;40(4):227-34. doi: 10.1111/j.1439-0272.2008.00848.x.

PMID:
18727732
6.

Effect of contrast application on interpretability and diagnostic value of dobutamine stress echocardiography in patients with intermediate coronary lesions: comparison with myocardial fractional flow reserve.

Jung PH, Rieber J, Störk S, Hoyer C, Erhardt I, Nowotny A, Voelker W, Weidemann F, Ertl G, Klauss V, Angermann CE.

Eur Heart J. 2008 Oct;29(20):2536-43. doi: 10.1093/eurheartj/ehn204. Epub 2008 May 21.

PMID:
18499651
7.

Biochemical and pharmacological investigations of selected cyanobacteria.

Mundt S, Kreitlow S, Nowotny A, Effmert U.

Int J Hyg Environ Health. 2001 May;203(4):327-34.

PMID:
11434213
8.

Potentiation of HIV envelope glycoprotein and other immunogens by endotoxin (ET) and its molecular fragments.

Kovats E, Somlyo B, Csanky E, Shi XM, Zhang YL, Coughlin RT, Nowotny A.

Int J Immunopharmacol. 1992 May;14(4):573-81.

PMID:
1521925
9.

Molecular requirements of endotoxin (ET) actions: changes in the immune adjuvant, TNF liberating and toxic properties of endotoxin during alkaline hydrolysis.

Somlyo B, Csanky E, Shi XM, Zhang YL, Kovats E, Bona-Liptak E, Nowotny AM, Tripodi D, Nowotny A.

Int J Immunopharmacol. 1992 Feb;14(2):131-42.

PMID:
1624214
10.
11.

Column liquid chromatography of endotoxins.

Somlyo B, Kovats E, Keler T, Nowotny A.

J Chromatogr. 1990 Feb 23;525(2):329-38.

PMID:
2184169
12.

Immunoadjuvanticity of endotoxins and nontoxic derivatives for normal and leukemic immunocytes.

Friedman H, Klein T, Specter S, Newton C, Nowotny A.

Adv Exp Med Biol. 1990;256:525-35.

PMID:
2183563
13.

Chemistry and biology of a novel lipid contaminant of some endotoxin preparations with selective cytotoxicity to transformed cells.

Keler T, Smith CA, Nowotny A.

Adv Exp Med Biol. 1990;256:163-84. No abstract available.

PMID:
2183550
14.

Isolation of a nonendotoxic antitumor preparation from Serratia marcescens.

Nowotny A, Keler T, Pham PH, Kovats E, Aiello A, Shonekan O, Friedman H, Johnson AG.

J Biol Response Mod. 1988 Jun;7(3):296-308.

PMID:
3292707
15.

Thin-layer chromatography of endotoxins, their derivatives and contaminants.

Samu J, Kováts E, Nguyen V, Keler T, Nowotny A, Coughlin RT.

J Chromatogr. 1988 Jan 1;435(1):167-83.

PMID:
3280582
16.
17.

Cytotoxicity of a novel lipid-like bacterial product.

Keler T, Kovats E, Nguyen V, Samu J, Sanavi F, Somlyo B, Nowotny A.

Biochem Biophys Res Commun. 1987 Dec 31;149(3):1033-41.

PMID:
3322284
18.

Enhanced antibody response in retrovirus-infected mice treated with endotoxin or nontoxic polysaccharide derivative.

Friedman H, Butler RC, Nowotny A.

Proc Soc Exp Biol Med. 1987 Dec;186(3):275-9.

PMID:
3423016
19.

Distinctive immunomodulatory effects of endotoxin and nontoxic lipopolysaccharide derivatives in lymphoid cell cultures.

Friedman H, Blanchard DK, Newton C, Klein T, Stewart W 2nd, Keler T, Nowotny A.

J Biol Response Mod. 1987 Dec;6(6):664-77.

PMID:
2453617
20.

Fetal alcohol syndrome. Eye malformations in a mouse model.

Cook CS, Nowotny AZ, Sulik KK.

Arch Ophthalmol. 1987 Nov;105(11):1576-81.

PMID:
3675291
21.

Review of the molecular requirements of endotoxic actions.

Nowotny A.

Rev Infect Dis. 1987 Sep-Oct;9 Suppl 5:S503-11. Review.

PMID:
3317746
22.

Interferon induction by endotoxin-derived nontoxic polysaccharides.

Nowotny A, Blanchard DK, Newton C, Klein T, Stewart W 2nd, Szentivanyi A, Friedman H.

J Interferon Res. 1987 Aug;7(4):371-8.

PMID:
2444655
23.

Time dependency of endotoxin-induced resistance to transplantable tumors in mice.

Nowotny A, Moore ME, Nejman G, Nowotny AM.

Cancer Invest. 1987;5(3):195-203.

PMID:
3308018
24.

Metachromatic assay for the quantitative determination of bacterial endotoxins.

Keler T, Nowotny A.

Anal Biochem. 1986 Jul;156(1):189-93.

PMID:
3740409
25.

The colonization and establishment of invading bacteria in periodontium of ligature-treated immunosuppressed rats.

Sanavi F, Listgarten MA, Boyd F, Sallay K, Nowotny A.

J Periodontol. 1985 May;56(5):273-80.

PMID:
3859633
26.

Biological effects of White-type polysaccharides of gram-negative bacteria.

Rothman J, Johnson AG, Friedman H, Kovats E, Pham PH, Sanavi F, Nowotny AM, Nowotny A.

J Biol Response Mod. 1985 Apr;4(2):169-84.

PMID:
3889227
27.

Effects of toxic and nontoxic endotoxin derivatives on glucose kinetics.

Lang CH, Bagby GJ, Nowotny A, Spitzer JJ.

Circ Shock. 1985;17(4):301-11.

PMID:
4092344
28.

Biological activities of lipopolysaccharide fractionated by preparative acrylamide gel electrophoresis.

Ohta M, Rothmann J, Kovats E, Pham PH, Nowotny A.

Microbiol Immunol. 1985;29(1):1-12.

29.

Effects of bacterial endotoxins and their detoxified derivatives on serum and liver lipids in mice.

Gaál D, Kremmer T, Bálint Z, Holczinger L, Bertók L, Nowotny A.

Toxicol Appl Pharmacol. 1984 Sep 30;75(3):437-43.

PMID:
6474473
30.

Bacterial invasion of oral tissues of immunosuppressed rats.

Sallay K, Listgarten M, Sanavi F, Ring I, Nowotny A.

Infect Immun. 1984 Mar;43(3):1091-3.

32.

Studies on the optimal conditions of CSF generation by endotoxic LPS and its PS derivative in mice.

Nowotny A, Behling UH, Madani F, Nowotny AM, Pham PH, Hertogs CF, Pluznik DH.

J Immunopharmacol. 1983;5(1-2):93-106.

PMID:
6606687
33.

Shedding eucaryotic cells.

Nowotny A.

Biomembranes. 1983;11:21-52. Review. No abstract available.

PMID:
6338948
34.

Shedding bacteria.

Nowotny A.

Biomembranes. 1983;11:1-20. Review. No abstract available.

PMID:
6187382
35.

Studies on host defenses enhanced by endotoxins: a brief review.

Nowotny A, Behling UH.

Klin Wochenschr. 1982 Jul 15;60(14):735-9. Review.

PMID:
6750227
36.

Release of toxic microvesicles by Actinobacillus actinomycetemcomitans.

Nowotny A, Behling UH, Hammond B, Lai CH, Listgarten M, Pham PH, Sanavi F.

Infect Immun. 1982 Jul;37(1):151-4.

37.

Alveolar bone destruction in the immunosuppressed rat.

Sallay K, Sanavi F, Ring I, Pham P, Behling UH, Nowotny A.

J Periodontal Res. 1982 May;17(3):263-74. No abstract available.

PMID:
6213757
38.

Humoral immunity and reduced periodontal bone loss in Eikenella corrodens-monoassociated rats.

Behling UH, Sallay C, Sanavi F, Pham PH, Nowotny A.

Infect Immun. 1981 Sep;33(3):801-5.

39.

Immunization against bacteria- and endotoxin-induced hypotension.

Abdelnoor AM, Johnson AG, Anderson-Imbert A, Nowotny A.

Infect Immun. 1981 Jun;32(3):1093-9.

40.
41.

Biological and chemical characterization of endotoxin from Capnocytophaga sputigena.

Stevens RH, Sela MN, McArthur WP, Nowotny A, Hammond BF.

Infect Immun. 1980 Jan;27(1):246-54.

42.

Lack of relationship between toxicity and bone marrow cell colony stimulating activity of endotoxin preparations.

Abdelnoor AM, Chang HL, Pham PH, Nowotny A.

Proc Soc Exp Biol Med. 1980 Jan;163(1):15-8. No abstract available.

PMID:
6965428
43.
44.

Restoration of depressed antibody responses of leukemic splenocytes treated with LPS-induced factors.

Butler RC, Friedman H, Nowotny A.

Adv Exp Med Biol. 1979;121(A):315-22.

PMID:
398146
45.

Studies on the endotoxin induced tumor resistance.

Nowotny A, Butler RC.

Adv Exp Med Biol. 1979;121B:455-69.

PMID:
397758
46.

Effect of immune sera upon enhanced in vitro antibody responses.

Frank SJ, Specter S, Nowotny A, Friedman H.

Adv Exp Med Biol. 1979;121B:261-7.

PMID:
397749
47.

Macrophage factors that enhance the antibody response.

Butler RC, Nowotny A, Friedman H.

Ann N Y Acad Sci. 1979;332:564-78.

PMID:
394644
48.

Role of bacterial products in periodontitis: humoral immune response to Eikenella corrodens.

Johnson DA, Behling UH, Listgarten M, Nowotny A.

Infect Immun. 1978 Nov;22(2):382-6.

49.

Suppression of the immune response in C3H/HeJ mice by protein-free lipopolysaccharides.

Haas GP, Johnson AG, Nowotny A.

J Exp Med. 1978 Oct 1;148(4):1081-6.

50.

Bone marrow colony-stimulating factor and tumor resistance-enhancing activity of postendotoxin mouse sera.

Butler RC, Abdelnoor AM, Nowotny A.

Proc Natl Acad Sci U S A. 1978 Jun;75(6):2893-6.

Supplemental Content

Loading ...
Support Center